IMX-1.png

Niël van Staden

Chief Investment Officer

Founder and CEO of Pronexus, a venture capital & financial services company
Previously with BNY Mellon with 12 years experience
Mergers & Acquisitions, Analytics and Valuations, Regulatory
Tax Change implementations, New Product Development
Experience Asset Management, Servicing and Global Markets
Headed up BioCertica investment
Top 15 African Healthtech startups by VivaTech, Deloitte, and IFC
Received innovation grant from the Bill and Melinda Gates Foundation

Leave a Reply

Your email address will not be published. Required fields are marked *